Rectal cancer affects the lowest part of the large bowel, close to the anal sphincter, which makes treatment planning more nuanced than for cancers higher in the colon. A multidisciplinary approach combining chemoradiation with precise surgical technique now allows the majority of patients to avoid a permanent colostomy.
Recognising the Symptoms
- Rectal bleeding or blood mixed with stool
- A persistent feeling of incomplete bowel emptying
- Narrow, ribbon-like stools
- Pelvic or rectal pain
- Unexplained weight loss
Diagnosis & Staging
MRI of the pelvis is central to rectal cancer staging, precisely mapping the tumour's relationship to the sphincter and surrounding structures. This, combined with CT of the chest and abdomen, determines whether neoadjuvant chemoradiation is needed before surgery.
Surgical Treatment
Total mesorectal excision (TME) is the standard operation, performed laparoscopically or robotically wherever possible. Careful case selection allows sphincter-preserving resection — such as low anterior resection or intersphincteric resection — in most patients, avoiding a permanent stoma.
Why Choose Dr. Abhishek Mitra
- Postdoctoral (HBNI) fellowship in GI & HPB Oncology from Tata Memorial Hospital, Mumbai
- Extensive experience in surgical oncology with minimally invasive and robotic techniques
- Multidisciplinary treatment planning coordinated with medical and radiation oncology
- Individualised surgical approach based on tumour stage, location, and patient fitness
Conclusion
Early diagnosis and expert surgical care make a significant difference in outcomes for Rectal Cancer. If you or a family member have been advised to consider treatment for this condition, a detailed evaluation can help determine the most appropriate course of care for your situation.
Concerned About Rectal Cancer?
Book a consultation with Dr. Abhishek Mitra for a thorough evaluation.